Overall, these associations, along with the marked reduction in TTR in obese adiposomes, may signal the loss of a key regulator of metabolic, vascular, and immune homeostasis, positioning TTR as a promising biomarker and therapeutic target in obesity. Here, TTR is linked to obesity due to melanocortin 4 receptor deficiency.